Estrella Immunopharma Inc (ESLA)

Finanzdaten der Estrella Immunopharma Inc-Aktie (ESLA)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	9.07%2.08	2.29	0.61	4.80	5.54
Research and Development	0.00%1.40	1.40	0.03	4.15	4.66
Other Operating Expenses	100.00%-	27.50	-	0.65	0.88
Operating Income/Loss	9.07%-2.08	-2.29	-0.61	-4.80	-5.54
Nonoperating Income/Loss	-0.22	-	-	-	-
Income/Loss From Continuing Operations Before Tax	0.62%-2.31	-2.29	-0.61	-4.80	-5.54
	0.62%-2.31	-2.29	-0.61	-4.80	-5.54
Attributable To Parent	0.62%-2.31	-2.29	-0.61	-4.80	-5.54
Basic Average Shares	2.08%43.00	42.12	-	37.10	36.17
Diluted Average Shares	2.08%43.00	42.12	-	37.10	36.17
Basic Earnings Per Share	-0.05	-0.05	-	-0.13	-0.15
Diluted Earnings Per Share	-0.05	-0.05	-	-0.13	-0.15